The current clinical assessment criterion for the condition of POF includes primary or secondary amenorrhea lasting more than four consecutive months and serum levels of FSH above 40 IU/l coupled with decreased estrogen levels[15]. This evidence concerns the gene BRD2 and premature menopause.